David A. Siegel Wave Life Sciences Ltd. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 86,100 shares of WVE stock, worth $429,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,100Holding current value
$429,639% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding WVE
# of Institutions
132Shares Held
71.8MCall Options Held
86.1KPut Options Held
20.1K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.69MShares$38.4 Million0.94% of portfolio
-
M28 Capital Management LP Stamford, CT7MShares$34.9 Million40.53% of portfolio
-
Black Rock Inc. New York, NY6.38MShares$31.8 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY5.35MShares$26.7 Million2.81% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.2MShares$26 Million0.06% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $433M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...